PHARMACOKINETICS OF CEFOTAXIME IN NEONATES

被引:29
作者
BAIRDLAMBERT, J [1 ]
DOYLE, PE [1 ]
THOMAS, D [1 ]
CVEJIC, M [1 ]
BUCHANAN, N [1 ]
机构
[1] UNIV SYDNEY,WESTMEAD CTR,WESTMEAD,NSW 2145,AUSTRALIA
关键词
D O I
10.1093/jac/13.5.471
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:471 / 477
页数:7
相关论文
共 19 条
[1]   METABOLISM OF CEFOTAXIME IN ANIMALS AND MAN [J].
CHAMBERLAIN, J ;
COOMBES, JD ;
DELL, D ;
FROMSON, JM ;
INGS, RJ ;
MACDONALD, CM ;
MCEWEN, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1980, 6 :69-78
[2]   TOXICOLOGY OF CEFOTAXIME IN COMPARISON TO OTHER CEPHALOSPORINS [J].
DOERR, BI ;
GLOMOT, R ;
KIEF, H ;
KRAMER, M ;
SAKAGUCHI, T .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1980, 6 :79-82
[3]   EFFECT OF PRENATAL EXPOSURE TO BETAMETHASONE ON METRONIDAZOLE ELIMINATION IN PREMATURE-INFANTS [J].
DOYLE, PE ;
JAGERROMAN, E ;
BAIRDLAMBERT, J ;
CVEJIC, M ;
BUCHANAN, N .
JOURNAL OF PEDIATRICS, 1982, 101 (04) :647-647
[4]   PHARMACOKINETICS OF CEFOTAXIME IN NORMAL HUMAN VOLUNTEERS [J].
ESMIEU, F ;
GUIBERT, J ;
ROSENKILDE, HC ;
HO, I ;
GO, AL .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1980, 6 :83-92
[5]   INCREASED THEOPHYLLINE METABOLISM IN PREMATURE-INFANTS AFTER PRENATAL BETAMETHASONE ADMINISTRATION [J].
JAGERROMAN, E ;
DOYLE, PE ;
THOMAS, D ;
BAIRDLAMBERT, J ;
CVEJIC, M ;
BUCHANAN, N .
DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS, 1982, 5 (3-4) :127-135
[6]  
KAFETZIS DA, 1982, J PEDIATR-US, V100, P483
[7]  
MAYER SE, 1980, PHARMACOL BASIS THER, P1
[8]   PHARMACOKINETICS OF CEFOTAXIME IN NEWBORN-INFANTS [J].
MCCRACKEN, GH ;
THRELKELD, NE ;
THOMAS, ML .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (04) :683-684
[9]   ANTI-BACTERIAL ACTIVITY OF CEFOTAXIME [J].
MITSUHASHI, S ;
INOUE, M ;
MASUYOSHI, S .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1980, 6 :37-46
[10]   RENAL FUNCTIONS AND CLINICAL DISORDERS IN THE NEONATE [J].
OH, W .
CLINICS IN PERINATOLOGY, 1981, 8 (02) :215-223